TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.
Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS.
Pirovano G, et al. Among authors: mckenna wg.
Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.
Br J Cancer. 2017.
PMID: 28677687
Free PMC article.